Error in Figure
In the original publication [1], there was a mistake in Figure 6 as published. During the manuscript preparation, panel I of Figure 6 was erroneously uploaded. The corrected Figure 6 appears below.
Figure 6In vitro model of BOLC development. (A) Immunocytochemical analysis of MDA-MB-231 alone (MDA-MB-231/CTRL) shows no/few vimentin-positive cells. (B) Several vimentin-positive MDA-MB-231 cells are present after co-culture with CO and activated monocytes. (C) The image displays the starting point of MDA-MB-231 cells incubated with CO and activated monocytes. (D) After 10 days of culture, several large, calcified nodules are present. (A–D) scale bars represent 100 µm. (E) Western blot analysis for tumor protein 53 (p53) and pyruvate kinase muscle (PKM) 2. (F) Western blot densitometric analysis (%) of p53 and PKM2 expression compared with the respective controls (MDA). (G,H) The ultrastructural aspect of MDA-MB-231 (CTRL). (I–K) Breast osteoblast-like cells with hydroxyapatite intra-cytoplasmatic electron-dense granules (arrows) in MDA-MB-231 + Co +-activated macrophages.
[Figure omitted. See PDF]
Moreover, the Editorial Board requested that the authors modify Figure 5 to include representative images of fibroadenoma areas with electron micrographs that better illustrate the observations made. The corrected Figure 5 appears below.
Figure 5Transmission electron microscopy of breast tissues. (A,B) Images show the ultrastructure of normal ducts in adjacent areas of fibroadenoma lesions. Both myoepithelial and luminal cells are displayed. (C,D) Fibroadenoma regions are characterized by epithelial breast cells (arrows), spindle cells (asterisks), and abundant stroma (arrow heads). (E) Infiltrating breast cancer is characterized by the presence of microcalcifications, and vimentin-, RANKL-, OPN-, BMP-2-, BMP-4-, and PTX3-positive cancer cells show several osteoblast-like cells. Asterisks mark a cell rich in endoplasmic reticulum, with a large nucleus and some electron-dense granules. Arrows mark a large cell with numerous electron-dense granules. (F) High magnification of panel E. The image displays electron-dense granules containing hydroxyapatite (asterisks) (energy-dispersive X-ray (Edx) spectrum). (G) Calcified nodule (asterisk) in breast infiltrating carcinoma. (H) Several cells surrounding the calcified nodule show large nuclei (asterisks) and collagen fibers both in intracellular and extracellular space. (I) High-magnification image of a cell next to the calcified nodule in panel (G). The electron micrograph shows the presence of fiber collagen in the cytoplasm of this cell.
[Figure omitted. See PDF]
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
1. Scimeca, M.; Bonfiglio, R.; Menichini, E.; Albonici, L.; Urbano, N.; De Caro, M.T.; Mauriello, A.; Schillaci, O.; Gambacurta, A.; Bonanno, E. Microcalcifications Drive Breast Cancer Occurrence and Development by Macrophage-Mediated Epithelial to Mesenchymal Transition. Int. J. Mol. Sci.; 2019; 20, 5633. [DOI: https://dx.doi.org/10.3390/ijms20225633] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31718020]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details




1 Department of Biomedicine and Prevention, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy;
2 Department of Experimental Medicine, University “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy;
3 Department of Clinical Sciences and Translational Medicine, University of Rome “Tor Vergata”, 00133 Rome, Italy;
4 Nuclear Medicine, Policlinico “Tor Vergata”, 00133 Rome, Italy;
5 Department of Biomedicine and Prevention, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy;
6 Department of Biomedicine and Prevention, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy;
7 Department of Experimental Medicine, University “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy;